COVID19 pandemic has positively impacted pneumonia therapeutics market, declaration by WHO that people suffering from COVID19 is highly susceptible to pneumonia
PORTLAND, OREGON, US, November 24, 2021 /EINPresswire.com/ — According to the report published by Allied Market Research, the global Pneumonia Therapeutics Market generated $12.2 billion in 2020, and is projected to reach $25.5 billion by 2030, witnessing a CAGR of 8.5% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Access Full Summary: https://www.alliedmarketresearch.com/pneumonia-therapeutics-market-A11230
Surge in prevalence of pneumonia, rise in geriatric population with weaker immune systems, increase in incidence and spending for community-acquired pneumonia, and rise in number of product launches drive the growth of the global pneumonia therapeutics market. However, high price of pneumonia therapeutics restrains the market to some extent. On the other hand, outbreak of novel viruses attacking respiratory system presents new opportunities in the upcoming years.
• The outbreak of the COVID-19 pandemic has positively impacted the pneumonia therapeutics market, owing to declaration by WHO that people suffering from COVID-19 is highly susceptible to pneumonia.
• Moreover, surge in R&D for the treatment of COVID-19 associated pneumonia has generated high revenue.
• However, dearth of workforce as well as resource limitations due to COVID-19 are expected to negatively impact the growth of the industry in the forecast period.
The report offers detailed segmentation of the global pneumonia therapeutics market based on therapeutics, distribution channel, age group, and region.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/11595
Based on therapeutics, the prevention vaccines segment held the highest market share in 2020, holding more than two-thirds of the total market share, and is expected to continue its leadership status during the forecast period. However, the treatment drugs segment is estimated to register the highest CAGR of 9.6% from 2021 to 2030.
Based on distribution channel, the hospitals segment held the largest market share in 2020, holding more than three-fifths of the total market share, and is expected to continue its leadership status during the forecast period. However, the pharmaceutical stores segment is projected to register the highest CAGR of 10.0% from 2021 to 2030.
Based on region, North America contributed to the highest share in terms of revenue in 2020, holding more than two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, LAMEA is projected to manifest the fastest CAGR of 12.0% during the forecast period.
Leading players of the global pneumonia therapeutics market analyzed in the research include Abbott Laboratories, Bayer AG, Eli Lilly & Company, Glaxosmithkline PLC., Lupin Pharmaceuticals, Inc., Merck KGAA, Novartis AG, Pfizer, Inc., Sanofi S.A., and Teva Pharmaceuticals Industries Limited.
Other Trending Reports:
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Source: EIN Presswire